PTGR1

Chr 9

prostaglandin reductase 1

Also known as: DIG-1, LTB4DH, PGR1, ZADH3

The encoded enzyme catalyzes the NADP+-dependent reduction of pro- and anti-inflammatory eicosanoids including prostaglandins, leukotrienes, and lipoxins, and also reduces cytotoxic aldehydes like 4-hydroxy-2-nonenal. Biallelic mutations in PTGR1 cause infantile-onset neurodegeneration with brain atrophy, characterized by severe developmental delay, seizures, and progressive brain volume loss. This gene follows autosomal recessive inheritance and is not highly constrained against loss-of-function variation.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.30
Clinical SummaryPTGR1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
32 unique Pathogenic / Likely Pathogenic· 47 VUS of 113 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.30LOEUF
pLI 0.000
Z-score 0.67
OE 0.82 (0.531.30)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.41Z-score
OE missense 0.91 (0.801.04)
164 obs / 179.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.82 (0.531.30)
00.351.4
Missense OE0.91 (0.801.04)
00.61.4
Synonymous OE0.94
01.21.6
LoF obs/exp: 13 / 15.9Missense obs/exp: 164 / 179.5Syn Z: 0.36
DN
0.80top 25%
GOF
0.6639th %ile
LOF
0.2483th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

113 submitted variants in ClinVar

Classification Summary

Pathogenic28
Likely Pathogenic4
VUS47
Likely Benign4
Benign2
28
Pathogenic
4
Likely Pathogenic
47
VUS
4
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
28
0
28
Likely Pathogenic
0
0
4
0
4
VUS
0
43
4
0
47
Likely Benign
0
4
0
0
4
Benign
0
0
2
0
2
Total04738085

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PTGR1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →